Gary Larson

1.6k total citations
60 papers, 1.3k citations indexed

About

Gary Larson is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology. According to data from OpenAlex, Gary Larson has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 16 papers in Radiation and 13 papers in Oncology. Recurrent topics in Gary Larson's work include Radiation Therapy and Dosimetry (17 papers), Advanced Radiotherapy Techniques (16 papers) and Prostate Cancer Diagnosis and Treatment (13 papers). Gary Larson is often cited by papers focused on Radiation Therapy and Dosimetry (17 papers), Advanced Radiotherapy Techniques (16 papers) and Prostate Cancer Diagnosis and Treatment (13 papers). Gary Larson collaborates with scholars based in United States, Norway and Italy. Gary Larson's co-authors include Jim Zhen Wu, Zhi Hong, Shunqi Yan, Carlos Vargas, T.C. Appleby, Robert Hamatake, William F. Hartsell, Nanhua Yao, Jae Hoon Shim and Henry Tsai and has published in prestigious journals such as Journal of Clinical Oncology, Biochemistry and Cancer.

In The Last Decade

Gary Larson

58 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary Larson United States	21	404	350	280	226	220	60	1.3k
Chung-Chi Lee Taiwan	16	235 0.6×	204 0.6×	212 0.8×	110 0.5×	216 1.0×	40	1.1k
Philip P. Connell United States	26	787 1.9×	722 2.1×	57 0.2×	261 1.2×	773 3.5×	69	2.4k
Akira Irie Japan	18	313 0.8×	331 0.9×	90 0.3×	38 0.2×	157 0.7×	78	1.3k
T C Stephens United Kingdom	17	423 1.0×	325 0.9×	84 0.3×	102 0.5×	470 2.1×	52	1.1k
Fumio Nakagawa Japan	20	381 0.9×	299 0.9×	78 0.3×	23 0.1×	682 3.1×	61	1.2k
P.W. Sheldon United Kingdom	24	431 1.1×	382 1.1×	140 0.5×	181 0.8×	319 1.4×	53	1.5k
Malte Kriegs Germany	23	810 2.0×	338 1.0×	76 0.3×	22 0.1×	640 2.9×	68	1.6k
Susan Cleator United Kingdom	20	714 1.8×	362 1.0×	43 0.2×	52 0.2×	996 4.5×	46	2.0k
Phillip J. Gray United States	17	457 1.1×	510 1.5×	43 0.2×	127 0.6×	292 1.3×	44	1.4k
Eric C. Ko United States	18	308 0.8×	314 0.9×	46 0.2×	61 0.3×	530 2.4×	47	1.2k

Countries citing papers authored by Gary Larson

Since Specialization

Citations

This map shows the geographic impact of Gary Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Larson more than expected).

Fields of papers citing papers by Gary Larson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Larson. The network helps show where Gary Larson may publish in the future.

Co-authorship network of co-authors of Gary Larson

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Larson. A scholar is included among the top collaborators of Gary Larson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Larson. Gary Larson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Larson, Gary, Jeffrey L. Thorne, & Scott C. Schmidler. (2020). Incorporating Nearest-Neighbor Site Dependence into Protein Evolution Models. Journal of Computational Biology. 27(3). 361–375. 8 indexed citations

Saeed, Ali, Rahul Khairnar, Ankur Sharma, et al.. (2020). Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry. Advances in Radiation Oncology. 5(5). 978–983. 27 indexed citations

Mishra, Mark V., Rahul Khairnar, Søren M. Bentzen, et al.. (2020). Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09. Clinical and Translational Radiation Oncology. 22. 50–54. 5 indexed citations

Mishra, Mark V., Rahul Khairnar, Søren M. Bentzen, et al.. (2019). Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09. Clinical and Translational Radiation Oncology. 19. 80–86. 13 indexed citations

Yu, Nathan Y., Mauricio E. Gamez, William F. Hartsell, et al.. (2019). A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors. Advances in Radiation Oncology. 4(4). 689–698. 30 indexed citations

Badiyan, Shahed N., Michael S. Rutenberg, Bradford S. Hoppe, et al.. (2019). Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies. Practical Radiation Oncology. 9(4). 280–288. 33 indexed citations

Tseng, Yolanda D., William F. Hartsell, Henry Tsai, et al.. (2018). Proton therapy patterns of care among pediatric and adult patients with CNS tumors. Neuro-Oncology. 20(11). 1556–1557. 5 indexed citations

Vargas, Carlos, Joshua R. Niska, William F. Hartsell, et al.. (2018). Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer. Advances in Radiation Oncology. 3(3). 322–330. 11 indexed citations

Mohindra, Pranshu, Yolanda D. Tseng, Shahed N. Badiyan, et al.. (2017). Proton Therapy for Lymphoma: A Multi-institutional Patterns of Care Study. International Journal of Radiation Oncology*Biology*Physics. 99(2). E433–E433. 1 indexed citations

10.

Badiyan, Shahed N., Pranshu Mohindra, Gary Larson, et al.. (2017). Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated with Proton Therapy on the Proton Collaborative Group Prospective Registry Trial. International Journal of Radiation Oncology*Biology*Physics. 99(2). S209–S209. 1 indexed citations

11.

Boimel, Pamela, Abigail T. Berman, Jonathan Li, et al.. (2017). Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma. Journal of Gastrointestinal Oncology. 8(4). 665–674. 19 indexed citations

12.

Morgan, Howard E., Vinai Gondi, Gary Larson, et al.. (2016). Low Levels of Acute Toxicity Associated With Proton Therapy for Low-Grade Glioma: A Proton Collaborative Group Study. International Journal of Radiation Oncology*Biology*Physics. 96(2). E135–E135. 13 indexed citations

13.

Vargas, Carlos, et al.. (2016). Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002. Reports of Practical Oncology & Radiotherapy. 21(3). 207–212. 20 indexed citations

14.

Zheng, Yuanshui, et al.. (2016). Minimizing treatment planning errors in proton therapy using failure mode and effects analysis. Medical Physics. 43(6Part1). 2904–2910. 9 indexed citations

15.

Rana, Suresh, et al.. (2014). Dosimetric impact of number of treatment fields in uniform scanning proton therapy planning of lung cancer. Journal of Medical Physics. 39(4). 212–212. 6 indexed citations

16.

Iverson, Cory, Gary Larson, Chon Lai, et al.. (2009). RDEA119/BAY 869766: A Potent, Selective, Allosteric Inhibitor of MEK1/2 for the Treatment of Cancer. Cancer Research. 69(17). 6839–6847. 153 indexed citations

17.

Hamatake, Robert, Li‐Tain Yeh, Hong Kim, et al.. (2007). RDEA119: A potent and highly selective MEK inhibitor for the treatment of cancer. Molecular Cancer Therapeutics. 6. 3 indexed citations

18.

Yan, Shunqi, Gary Larson, Jim Zhen Wu, et al.. (2006). Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure. Bioorganic & Medicinal Chemistry Letters. 17(1). 63–67. 46 indexed citations

19.

Ding, Yili, Jean‐Luc Girardet, Kenneth L. Smith, et al.. (2005). Parallel synthesis of 5-cyano-6-aryl-2-thiouracil derivatives as inhibitors for hepatitis C viral NS5B RNA-dependent RNA polymerase. Bioorganic Chemistry. 34(1). 26–38. 49 indexed citations

20.

Ding, Yili, Jean‐Luc Girardet, Kenneth L. Smith, et al.. (2004). Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 15(3). 675–678. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact